Advanced search
Publication Cover
Journal of Medical Economics Volume 22, 2019 - Issue 8
Submit an article Journal homepage
3,931
Views
4
CrossRef citations to date
0
Altmetric
Oncology

A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in four European countries: Austria, Belgium, Greece, and Italy

Evangelos Terposa Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece; Correspondence[email protected]
,
Aurelien Jamotteb Global Health Economics, Amgen (Europe) GmbH, Rotkreuz, Switzerland;
,
Alexandra Christodoulopoulouc Global Health Economics, Amgen Inc, Thousand Oaks, CA, USA;
,
Marco Campionib Global Health Economics, Amgen (Europe) GmbH, Rotkreuz, Switzerland;
,
Debajyoti Bhowmikc Global Health Economics, Amgen Inc, Thousand Oaks, CA, USA;
,
Lisa Kennedyd Epiphany, Los Angeles, CA, USA;
&
Wolfgang Willenbachere Department of Internal Medicine V, Innsbruck University Hospital & Oncotyrol, Center for Personalized Cancer Medicine, Innsbruck, Austria
 show all
Pages 766-776 | Received 21 Feb 2019, Accepted 05 Apr 2019, Published online: 29 Apr 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.